Browse resources

Region: North America and Europe

Total results with these characteristics: 157

Page 5 of 7  
‹ prev.
2
3
4
5
6
7
next ›

Pneumococcus

This article, published in Medical Clinics of North America, summarizes the risk factors, pathogenesis, treatment, and prevention of the spectrum of disease caused by pneumococcus with particular emphasis on antibiotic resistance as well as …

Author: Ash SY, Sheffield JV

Published: 2013

Policy Reaction to Thimerosal in Vaccines

This study compares the differences in US and European responses to concerns about mercury exposure from thimerisol in vaccines.

Author: Child Health Evaluation and Research Unit, University of Michigan Medical Center & Duke University Medical Center

Published: 2001

Post-licensure Evaluation of the Effectiveness of Seven-valent Pneumococcal Conjugate Vaccine

Published in the Pediatric Infectious Disease Journal, this study evaluates the impact of the introduction and routine use of seven valent pneumococcal conjugate vaccine on the epidemiology of invasive pneumococcal disease within the …

Author: Black S, Shinefield HR, Hansen J, et al.

Published: 2001

Postmarketing Monitoring of Intussusception After RotaTeq Vaccination-United States, February 1, 2006 - February 15, 2007

This article, published in Morbidity and Mortality Weekly Report, summarizes the Advisory Committee on Immunization Practices review of post-marketing safety surveillance data on RotaTeq®, the rotavirus vaccine by Merck & Co., Inc. The …

Author: US Centers for Disease Control and Prevention

Published: 2007

Potential Impact of Accelerating the Primary Dose of Pneumococcal Conjugate Vaccine in Infants

This article, published in Archives of Pediatrics and Adolescent Medicine, estimates the potential effect of the acceleration of administration of the first dose of pneumococcal conjugate vaccine from two months to six weeks of age. The …

Author: Stancil JM, Peters TR, Givner LB, Poehling KA

Published: 2009

Potential Intussusception Risk Versus Benefits of Rotavirus Vaccination in the United States

International data show a low-level increased risk of intussusception associated with rotavirus vaccination. This article, published in the Pediatric Infectious Disease Journal, reports on a study that compared potential vaccine-associated …

Author: Rishi D, Cortese M, Meltzer MI, et al.

Published: 2013

Pragmatic Management of Programmatic Vaccination Errors—Lessons Learnt from Incidents in London

Correct storage, handling, and administration of vaccines are vital components of a successful immunization program. However, with the large number of different healthcare professionals now involved in delivering vaccine programs on a daily …

Author: Craig L, Elliman D, Heathcock R, Turbitt D, Walsh B, Crowcroft N

Published: 2010

Prevenar™ Vaccination: Review of the Global Data, 2006

This article, published in the journal Vaccine, reviews the incidence of vaccine-serotype invasive pneumococcal disease and other pneumococcal-associated respiratory tract diseases following the routine use of the seven-valent pneumococcal conjugate …

Author: Center KJ

Published: 2007

Prevent Childhood Influenza

This website provides materials about childhood influenza vaccination in the United States. It is targeted to both consumer and healthcare professionals. Materials include fact sheets, videos, social media sharing tools, real-life stories, …

Author: National Foundation for Infectious Diseases, Childhood Influenza Immunization Coalition

Prevention of Meningococcal Disease: Current Use of Polysaccharide and Conjugate Vaccines

Invasive meningococcal disease (IMD) is a serious public health threat, characterized by rapid symptom onset and high fatality rate, even after treatment. Efforts to prevent IMD remain challenging, because there is neither an immunogenic vaccine for …

Author: Poland GA

Published: 2010

Prevention of Pneumococcal Disease Among Infants and Children --- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine

This report, published by the US Centers for Disease Control and Prevention (CDC), summarizes recommendations approved by the CDC's Advisory Committee on Immunization Practices (ACIP) on February 24, 2010, for the use of 13-valent …

Author: US Centers for Disease Control and Prevention

Published: 2010

Prevention of Serious Respiratory Syncytial Virus-Related Illness. II: Immunoprophylaxis

This article, published in Advances in Therapy, reviews the development and use of palivizumab, the only drug approved for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease. Palivizumab is a monoclonal antibody that …

Author: Groothuis JR, Hoopes JM, Hemming VG

Published: 2011

Projected Cost-Effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young Children

This study, published in the Journal of American Medical Association, evaluates the projected health and economic impact of pneumococcal conjugate vaccination of healthy US infants and young children through a cost-effectiveness analysis based …

Author: Lieu TA, Ray GT, Black SB, et al.

Published: 2000

Prospects for Vaccine Prevention of Meningococcal Infection

This article, published in Clinical Microbiology Reviews, reviews the changing epidemiology of meningococcal disease in the United States, issues related to vaccine prevention, and recommendations on the use of the polysaccharide conjugate …

Author: Harrison LH

Published: 2006

Protecting Public Trust in Immunization

This article, published in Pediatrics, discusses the issue of public trust in the safety and efficacy of vaccines and how it is one key to the success of immunization programs within the United States and globally. Allegations of harm from …

Author: Cooper LZ, Larson HJ, Katz SL

Published: 2008

Protection From Routine Vaccination at the Age of 14 Months With Meningococcal Serogroup C Conjugate Vaccine in the Netherlands

This article, published in The Pediatric Infectious Disease Journal, reviews routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and a catch-up campaign, which has reduced the incidence of meningococcal C …

Author: de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van Derende A

Published: 2006

Protective Association Between Rotavirus Vaccination and Childhood Seizures in the Year Following Vaccination in US Children

This article, published in Clinical Infectious Diseases, describes a review of data from 250,000 children born in the United States between March 2006—when rotavirus vaccines were introduced in the United States—and November 2009 for incidences …

Author: Payne DC, Baggs J, Zerr DM, et al.

Published: 2013

Provider Resources for Vaccine Conversations with Parents

In partnership with the American Academy of Pediatrics and the American Academy of Family Physicians, the US Centers for Disease Control and Prevention created this suite of materials to support the conversations that healthcare providers are …

Author: US Centers for Disease Control and Prevention

Published: 2012

Questions Frequently Asked About Hepatitis B

Helpful information about hepatitis B risks, transmission, symptoms, and prevention through immunization.

Author: Immunization Action Coalition

Published: 2007

Questions Parents Ask About Baby Shots

This simple, attractive, trifold brochure for parents was created by the Child Vaccination Program in New York City and was modified and reprinted by the Immunization Action Coalition.

Author: Child Vaccination Program/Immunization Action Coalition

Published: 2000

Rapid Disappearance of Haemophilus influenzae type b Meningitis After Routine Childhood Immunization with Conjugate Vaccines

This study, published in The Lancet, carried out a retrospective survey of the incidence of Hib meningitis over five decades in the Greater Helsinki area of Finland, where all children with bacterial meningitis are treated in one of three …

Author: Peltola H, Kilpi T, Anttila M

Published: 1992

Reactive Arthritis Following Culture-Confirmed Infections with Bacterial Enteric Pathogens in Minnesota and Oregon: A Population-based Study

This article, published in Annals of the Rheumatic Diseases, describes the epidemiology and clinical spectrum of reactive arthritis (ReA) following culture-confirmed infection with bacterial enteric pathogens in a population-based study in …

Author: Townes JM, Deodhar AA, Laine ES, et al.

Published: 2008

Reduction in Acute Gastroenteritis Hospitalizations Among US Children After Introduction of Rotavirus Vaccine: Analysis of Hospital Discharge Data from 18 US States

This study, published in The Journal of Infectious Diseases, shows a dramatic reduction of acute gastroenteritis hospitalizations in the United States following the 2006 introduction of the RotaTeq® rotavirus vaccine. The study gathered …

Author: Curns AT, Steiner CA, Barrett M, et al.

Published: 2010

Respiratory Syncytial Virus Disease in Infants Despite Prior Administration of Antigenic Inactivated Vaccine

This article, published in the American Journal of Epidemiology, details studies conducted to determine the ability of a formalin inactivated vaccine candidate to protect against respiratory syncytial virus (RSV) disease. Results from the study …

Author: Kim HW, Canchola JG, Brandt CD, et al.

Published: 1969

Respiratory Syncytial Virus Infection (RSV)

This web page provides a wide spectrum of information about respiratory syncytial virus (RSV) in the United States. It offers a general overview of the disease as well as clinical, research, and surveillance information. Specific topics include, …

Author: US Centers for Disease Control and Prevention

Page 5 of 7  
‹ prev.
2
3
4
5
6
7
next ›